What lab evaluations are recommended for monitoring in preeclampsia?

In the context of monitoring preeclampsia, certain lab evaluations are critical for assessing the mother's and fetus’s health. A complete blood count (CBC) is essential for evaluating hemoglobin levels, platelet counts, and signs of hemolysis, which can indicate worsening disease. Urinalysis is also vital, as it helps in detecting proteinuria, which is a diagnostic criterion for preeclampsia.

Additionally, measuring liver enzymes such as AST (aspartate aminotransferase) and ALT (alanine aminotransferase) is important because elevated liver enzymes can signal liver dysfunction, which can occur in severe cases. Uric acid levels may also be monitored since they can rise in preeclampsia, reflecting the underlying pathophysiology of the condition.

The combination of these assessments allows for comprehensive monitoring of the progression of preeclampsia. The pairing of CBC and urinalysis provides key insights into maternal wellbeing, while AST/ALT and uric acid levels further clarify any potential liver involvement and metabolic stress. Thus, selecting both sets of lab tests gives a fuller picture of the patient's condition in the context of preeclampsia.